SCHEMBL7929207

SCHEMBL7929207

CCCCC(C(=O)O)(c1ccc2ccccc2c1)C(C)P(=O)(O)Cc1ccccc1

nearest known ligand 0.41

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
PTPN1 P18031 5/20 0.41
CETP P11597 4/20 0.40
RAB9A P51151 2/20 0.39
SMN1; SMN2 Q16637 2/20 0.39
NPC1 O15118 1/20 0.39
LMNA P02545 1/20 0.39
CNR1 P21554 1/20 0.37
CNR2 P34972 1/20 0.37
EPHX1 P07099 1/20 0.37
HDAC3 O15379 1/20 0.36
HDAC1 Q13547 1/20 0.36
HDAC2 Q92769 1/20 0.36
GAA P10253 1/20 0.35
BCHE P06276 1/20 0.35
REN P00797 1/20 0.35
PPARG P37231 2/20 0.34
PPARA Q07869 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7931864 0.83 PTPN1 (0.44) PTPN1CETPRAB9ASMN1; SMN2NPC1
SCHEMBL7931915 0.83 CETP (0.41) PTPN1CETPRAB9ASMN1; SMN2NPC1
SCHEMBL7919970 0.79 PTPN1 (0.42) PTPN1PPARGPPARA
SCHEMBL7609842 0.78 PTPN1 (0.43) PTPN1CETPRAB9ASMN1; SMN2NPC1
SCHEMBL7610593 0.76 PTPN1 (0.41) PTPN1CETPRAB9ASMN1; SMN2NPC1
SCHEMBL7610316 0.76 CETP (0.45) PTPN1CETPRAB9ASMN1; SMN2NPC1
SCHEMBL7926749 0.76 PTPN1 (0.43) PTPN1CETPRAB9ASMN1; SMN2NPC1
SCHEMBL7607399 0.74 PTPN1 (0.47) PTPN1CETPRAB9ASMN1; SMN2NPC1
SCHEMBL7928443 0.73 ACP3 (0.39) CETPCNR1CNR2
SCHEMBL7300743 0.73 SMN1; SMN2 (0.44) PTPN1CETPRAB9ASMN1; SMN2NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0994707-A4 INHIBITORS OF NAALADASE ENZYME ACTIVITY GUILFORD PHARM INC (US) 2001-11-14 EP claimed
EP-0994707-A1 INHIBITORS OF NAALADASE ENZYME ACTIVITY GUILFORD PHARMACEUTICALS INC. (US) 2000-04-26 EP claimed
WO-1998053812-A1 INHIBITORS OF NAALADASE ENZYME ACTIVITY GUILFORD PHARMACEUTICALS INC. (US) 1998-12-03 WO claimed
EP-0994707-A4 INHIBITORS OF NAALADASE ENZYME ACTIVITY GUILFORD PHARM INC (US) 2001-11-14 EP disclosed
EP-0994707-A1 INHIBITORS OF NAALADASE ENZYME ACTIVITY GUILFORD PHARMACEUTICALS INC. (US) 2000-04-26 EP disclosed
WO-1998053812-A1 INHIBITORS OF NAALADASE ENZYME ACTIVITY GUILFORD PHARMACEUTICALS INC. (US) 1998-12-03 WO disclosed